Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11

BackgroundIrritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Probiotic-based strategies are increasingly being explored for IBS management, with growing interest in strain-specific app...

Full description

Bibliographic Details

Published in:	Frontiers in Medicine
Main Authors:	Alexander Bertuccioli, Davide Sisti, Nadia Lazzerini, Chiara Maria Palazzi, Giordano Bruno Zonzini, Mirko Ragazzini, Annalisa Belli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	irritable bowel syndrome Clostridium butyricum CBM588 Bifidobacterium longum W11 probiotics IBS-D IBS-C
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1604319/full